Bristol Myers Squibb reports positive Phase 3 results for admilparant in idiopathic pulmonary fibrosis

Camurus receives Canadian approval for Oczyesa XR for acromegaly

Perceptive Discovery partners with Nucleus RadioPharma Inc to accelerate radiopharmaceutical development

Akeso reports first patient dosed in Phase III study of cadonilimab in colon cancer

Glaukos reports positive Phase 4 results for iDose TR with cataract surgery

Medincell partner Teva secures FDA approval for monthly schizophrenia treatment

Alumis reports new Phase 3 data showing sustained skin clearance with envudeucitinib

FDA approves Genentech's Tecentriq combination therapy for stage III colon cancer

Sophos IRB and ALCMI partner to support lung cancer research

Innovent Biologics achieves primary study endpoint for inactive thyroid eye disease antibody

argenx reports positive Phase 2 results for FB102 in coeliac disease

Vir Biotechnology's VIR-5500 receives FDA Fast Track designation for prostate cancer

FDA accepts Bayer's application for KERENDIA in chronic kidney disease without diabetes

WuXi AppTec awarded EcoVadis gold medal for third year

Suzhou Ribo Life Science submits Phase I Clinical Trial Application for RBD3133 in EU